Nantara Durrani, MBBS | |
2626 Capital Medical Blvd, Tallahassee, FL 32308-4402 | |
(850) 325-5885 | |
Not Available |
Full Name | Nantara Durrani |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2626 Capital Medical Blvd, Tallahassee, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003070814 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | ME104479 (Florida) | Secondary |
207R00000X | Internal Medicine | A107752 (California) | Secondary |
208M00000X | Hospitalist | A107752 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nantara Durrani, MBBS 3909 Reserve Dr, Apartment No:1028, Tallahassee, FL 32311-8200 Ph: (862) 596-5469 | Nantara Durrani, MBBS 2626 Capital Medical Blvd, Tallahassee, FL 32308-4402 Ph: (850) 325-5885 |
News Archive
Although sickle cell disease is a single-gene disorder, its symptoms are highly variable. In a study published online July 14 by the Proceedings of the National Academy of Sciences, scientists at Children's Hospital Boston and the Dana Farber Cancer Institute (DFCI), in collaboration with the Broad Institute of MIT and Harvard, report five gene variants that could potentially be helpful in predicting sickle cell disease severity, perhaps even leading to better treatment approaches in the future.
COVID-19 is not the flu. The disease caused by the novel SARS-CoV-2 virus is more transmissible, and deadlier, than most influenza epidemics we've encountered in our lifetimes, and scientists and physicians are still learning new things about the disease and its long-term effects.
Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).
A new review indicates that there is a massive problem of self-medication misuse in the Middle East. The findings, which are published in Pharmacology Research & Perspectives, indicate the need for better patient and physician education, as well as improved policies that restrict sales of prescription medications without a prescription.
BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft ("Augment"), to autograft for use in hindfoot and ankle fusion surgery.
› Verified 1 days ago
Adam Chong Joo, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Miccosukee Rd, Hospitalist Group, Tallahassee, FL 32308 Phone: 850-431-4996 Fax: 850-431-6315 | |
Steele Lancaster, MD Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 1300 Miccosukee Road, Hospitalist Group, Tallahassee, FL 32308 Phone: 850-431-4556 Fax: 850-431-6315 | |
Dr. Aaron Chen, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2626 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-325-5000 | |
Raymond James Shashaty, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Miccosukee Rd, Hospitalist Group, Tallahassee, FL 32308 Phone: 850-431-4996 Fax: 850-431-6315 | |
Mark Wheeler, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Miccosukee Rd, Hospitalist Group, Tallahassee, FL 32308 Phone: 850-431-4996 Fax: 850-431-6315 | |
Jasmine Rivas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Miccosukee Rd, Tallahassee, FL 32308 Phone: 850-431-4556 | |
Nicky Lamar Nelson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Miccosukee Rd, Hospitalist Group, Tallahassee, FL 32308 Phone: 850-431-4996 Fax: 850-431-6315 |